Praised by one client for its 'very detailed knowledge of venture capital market practices' and billed by another as 'the reference in Paris’, the Jones Day team excels at delivering counsel on venture and growth capital matters, from seed to late stage financing. The group assists start-ups and multinationals alike and has particular expertise with regards the tech and biotech segments. The practice is jointly led by a group of four partners, comprising: Renaud Bonnet, Charles Gavoty, Jean-Gabriel Griboul, and Geoffroy Pineau-Valencienne. Anne Kerneur is an additional key contact. Alexandre Wibaux relocated to the firm's New York office.
Testimonials
Collated independently by Legal 500 research team.
‘The Jones Day team is exceptional in its ability to handle all types of files with consistent quality. The reference in Paris.’
‘Charles Gavoty is a high-quality professional - a negotiation alongside him or across from him is always fluid and balanced, so that everyone comes out of it satisfied.’
‘Very detailed knowledge of venture capital market practices. Very strong involvement of the most senior members of the firm.'
‘They truly understand us as a client and strongly have our interests at heart. They are able to do this with empathy and care for both sides which I think is key in their execution.’
Key clients
- Amolyt Pharma
- Elaia Partners
- Incepto Medical
- Shippeo
- EarlyBird Venture Capital
- EcoVadis
- Pigment
- Bpifrance, Eurazeo and ContentSquare
- Creadev and Temasek
- Fintecture
- Debiopharm
- Portage and Orange Ventures
- Opera Tech Ventures (VC arm of BNP Paribas)
- Castor
- Bpifrance (SPI fund), GoCapital and NCI
- Omnes Capital
- Ledger
- CVE
- Welcome to the Jungle
- Hi inov and Demeter
Lawyers
Practice head
The lawyer(s) leading their teams.
Renaud D. Bonnet, Charles Gavoty, Jean-Gabriel Griboul, Geoffroy Pineau-Valencienne